Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$16,482,653
+$1,474,037 QoQ
Shares Held
64,900
+5.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#835
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PAYDEN & RYGEL holds $102,478,534 across 7 Drug Manufacturers - General names. JNJ ranks #4 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
200,960 | $25,823,360 | |
| 2 | ABBV |
AbbVie Inc.
|
73,250 | $18,432,630 | |
| 3 | LLY |
ELI LILLY & Co
|
14,670 | $17,595,639 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
64,900 | $16,482,653 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
126,560 | $15,989,590 | |
| 6 | PFE |
Pfizer Inc
|
311,580 | $7,502,846 | |
| 7 | AMGN |
Amgen Inc
|
1,800 | $651,816 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,482,653 | 64,900 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $15,008,616 | 61,400 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $12,706,730 | 61,400 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $12,033,758 | 64,900 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $9,913,475 | 64,900 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $10,763,016 | 64,900 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,350,940 | 37,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,098,228 | 43,800 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $6,401,808 | 43,800 | Shares | Sole | 2024-10-07 | |
| 2024-03-31 | $14,379,471 | 90,900 | Shares | Sole | 2024-10-08 | |
| 2023-12-31 | $12,272,742 | 78,300 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,195,225 | 78,300 | Shares | Sole | 2024-10-07 | |
| 2023-06-30 | $13,241,600 | 80,000 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $19,127,000 | 123,400 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $20,844,700 | 118,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $19,276,480 | 118,000 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $20,449,152 | 115,200 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $20,416,896 | 115,200 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $29,133,221 | 170,300 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $27,503,450 | 170,300 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $27,017,360 | 164,000 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $27,084,880 | 164,800 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $25,432,608 | 161,600 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $24,059,008 | 161,600 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $16,341,206 | 116,200 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $15,237,306 | 116,200 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||